Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Xinyu Li

Xinyu Li

BSc, MPhil, Dr


Early Career Research Fellow

Xinyu Li is an NDPH Early Career Research Fellow at the Health Economics Research Centre (HERC). Her fellowship focuses on enhancing decision-making for type 2 diabetes by validating and updating the UKPDS Outcomes Model 2, exploring the potential of data-driven diabetes subgroups, and investigating the generalizability of trial evidence to real-world populations.

Before joining HERC, Xinyu was a postdoctoral researcher at Maastricht University Medical Center, focusing on the discovery and validation of heart failure subtypes. She completed her PhD at the University of Groningen, specialising in simulation modelling, economic evaluation, and data-driven subgroup analysis. As part of the IMI RHAPSODY project, she researched diabetes subgroups and tailored approaches for type 2 diabetes management.

During her PhD, she also worked at the Dutch National Institute for Public Health and the Environment and contributed to projects commissioned by the Dutch Healthcare Institute and the Dutch Ministry of Health, including the development of disease models to support coverage decisions and the revision of public health models. She was also a researcher at Utrecht University within the EU Horizon 2020 HTx project, working on next-generation health technology assessment.

Xinyu holds an MPhil in Finance and Economics from the University of Cambridge and a BSc in Mathematics with Finance from the University of Liverpool.

Her research interests span health economics, simulation modelling, and economic evaluation, with a focus on applying these methods to inform policy decision-making in diabetes, heart failure, mental health, and other chronic diseases.